News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
539,579 Results
Type
Article (21189)
Company Profile (181)
Press Release (518206)
Multimedia
Podcasts (79)
Webinars (9)
Section
Business (178056)
Career Advice (376)
Deals (27246)
Drug Delivery (49)
Drug Development (59842)
Employer Resources (29)
FDA (11177)
Job Trends (9581)
News (257404)
Policy (19954)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (1)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (4)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (1)
Academia (1275)
Academic (1)
Accelerated approval (43)
ADA (23)
Adcomms (12)
Allergies (106)
Alliances (36802)
ALS (175)
Alzheimer's disease (1190)
Antibody-drug conjugate (ADC) (379)
Approvals (11744)
Artificial intelligence (489)
ASCO (194)
Autoimmune disease (294)
Automation (45)
Bankruptcy (279)
Belgium (7)
Best Places to Work (7700)
BIO (49)
Biologics (59)
BIOSECURE Act (5)
Biosimilars (133)
BioSpace Insights (58)
Biotechnology (120)
Bispecific (26)
Bladder cancer (166)
Brain cancer (51)
Breast cancer (638)
Cancer (4828)
Cardiovascular disease (318)
Career advice (323)
Career pathing (7)
CAR-T (286)
CDC (10)
CDMO (86)
Celiac Disease (4)
Cell-line development (2)
Cell therapy (845)
Cervical cancer (39)
Clinical research (53806)
Collaboration (1676)
Commercialization (30)
Company closure (2)
Compensation (1630)
Complete response letters (56)
COVID-19 (1046)
CRISPR (138)
CRO (2)
C-suite (1018)
Cystic fibrosis (153)
Data (7409)
Decentralized trials (1)
Denatured (14)
Depression (113)
Dermatology (112)
Diabetes (424)
Diagnostics (4935)
Digital health (42)
Diversity (2)
Diversity, equity & inclusion (8)
Drug discovery (247)
Drug pricing (31)
Drug shortages (3)
Duchenne muscular dystrophy (327)
Earnings (76490)
Editorial (25)
Employer branding (4)
Employer resources (31)
ESMO (278)
Events (94994)
Executive appointments (835)
Eye disease (9)
FDA (14479)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (4)
Friedreich's ataxia (26)
Frontotemporal dementia (31)
Funding (1259)
Gene editing (298)
Generative AI (26)
Gene therapy (947)
GLP-1 (420)
Government (1388)
Grass and pollen (2)
Guidances (305)
Healthcare (10678)
Hematology (120)
HIV (63)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (99)
Immunology and inflammation (148)
Immuno-oncology (89)
Indications (208)
Infectious disease (1279)
Inflammatory bowel disease (158)
Inflation Reduction Act (5)
Influenza (97)
Intellectual property (288)
Interviews (53)
IPO (13001)
IRA (4)
Job creations (2226)
Job search strategy (294)
JPM (19)
Kidney cancer (19)
Kidney disease (112)
Labor market (17)
Layoffs (169)
Leadership (7)
Legal (5496)
Licensing (61)
Liver cancer (58)
Longevity (32)
Lung cancer (702)
Lung diease (9)
Lymphoma (343)
Machine learning (37)
Management (7)
Manufacturing (849)
Marketing (22)
MASH (144)
Medical affairs (2)
Medical device (9145)
Medtech (9348)
Mergers & acquisitions (15417)
Metabolic disorders (934)
mRNA (140)
Multiple sclerosis (153)
Multispecific (4)
NASH (7)
Netherlands (6)
Neurodegenerative disease (355)
Neuropsychiatric disorders (52)
Neuroscience (2448)
Neurotech (2)
NextGen: Class of 2026 (3673)
Non-profit (1370)
Now hiring (13)
Obesity (330)
Opinion (98)
Ovarian cancer (200)
Pain (217)
Pancreatic cancer (258)
Parkinson's disease (275)
Partnered (24)
Patents (562)
Patient advocacy (3)
Patient recruitment (631)
Patient selection (57)
Peanut (33)
People (44667)
Peptides (19)
Pharmaceutical (32)
Pharmacy benefit managers (10)
Phase 1 (17741)
Phase 2 (24082)
Phase 3 (16575)
Pipeline (9550)
Policy (97)
Postmarket research (1692)
Preclinical (7745)
Press Release (69)
Prostate cancer (231)
Psychedelics (20)
Radioligand (1)
Radiopharmaceuticals (216)
Rare diseases (1143)
Real estate (3429)
Recruiting (14)
Regenerative medicine (22)
Regulatory (17394)
Reports (28)
Research institute (1193)
Resumes & cover letters (54)
Rett syndrome (58)
RNA editing (26)
RSV (54)
Schizophrenia (124)
Series A (212)
Series B (153)
Service/supplier (5)
Sickle cell disease (126)
Special edition (10)
Spinal muscular atrophy (172)
Sponsored (21)
Startups (2473)
State (1)
Stem cells (4)
Stomach cancer (11)
Substance use disorders (16)
Supply chain (70)
Switzerland (3)
Tariffs (17)
Tax incentives (1)
The Weekly (64)
Vaccines (455)
Venture capital (46)
Weight loss (121)
Wet AMD (6)
Women's health (106)
Date
Last 7 days (553)
Last 30 days (1932)
Last 365 days (21622)
2026 (18044)
2025 (21728)
2024 (25782)
2023 (29439)
2022 (37997)
2021 (40508)
2020 (36554)
2019 (26478)
2018 (19777)
2017 (21027)
2016 (20098)
2015 (26399)
2014 (23245)
2013 (25152)
2012 (21584)
2011 (21712)
2010 (21466)
Location
Africa (308)
Alabama (82)
Alaska (3)
Arizona (350)
Arkansas (13)
Asia (22671)
Australia (3229)
California (13729)
Canada (3522)
China (855)
Colorado (551)
Connecticut (509)
Delaware (248)
Europe (38413)
Florida (2003)
Georgia (418)
Hawaii (4)
Idaho (49)
Illinois (887)
India (79)
Indiana (373)
Iowa (27)
Japan (516)
Kansas (106)
Kentucky (40)
Louisiana (36)
Maine (30)
Maryland (1421)
Massachusetts (9385)
Michigan (335)
Minnesota (646)
Mississippi (5)
Missouri (93)
Montana (20)
Nebraska (12)
Nevada (137)
New Hampshire (64)
New Jersey (3083)
New Mexico (14)
New York (3289)
North Carolina (1484)
North Dakota (12)
Northern California (7046)
Ohio (355)
Oklahoma (15)
Oregon (20)
Pennsylvania (2572)
Puerto Rico (25)
Rhode Island (42)
South America (497)
South Carolina (83)
South Dakota (1)
Southern California (5601)
Tennessee (139)
Texas (2245)
United States (45207)
Utah (410)
Vermont (1)
Virginia (213)
Washington D.C. (42)
Washington State (1090)
West Virginia (2)
Wisconsin (97)
Wyoming (2)
539,579 Results for "trucode gene repair inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ECM Therapeutics Reports Promising Results in Fistula Repair
October 13, 2026
·
2 min read
FDA
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
The FDA has outlined a process for allowing a single application to cover multiple variants of a gene therapy. At the same time, the Centers for Medicare & Medicaid Services has revealed plans to expand the Cell and Gene Therapy Access Model to increase patient access to these products.
October 28, 2026
·
4 min read
·
Heather McKenzie
Venture capital
Estuary sails into kidney disease space with $103M for gene therapies
Estuary Biotherapeutics is seeking to address the root cause of autosomal dominant polycystic kidney disease with two gene therapy programs based on science from Yale.
October 16, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Vincora Receives FDA Approval to Initiate U.S. Early Feasibility Study of Transcatheter Chordal Repair System
October 27, 2026
·
3 min read
Rett syndrome
Neurogene, Taysha near finish line in ‘two-horse race’ for first Rett syndrome gene therapy
As both Taysha Gene Therapies and Neurogene warm up for an important year of readouts, the Rett syndrome community is hopeful of seeing a therapy that can truly change the disease’s path.
October 26, 2026
·
6 min read
·
Michael Gibney
Opinion
Blood centers can help biopharma scale cell and gene therapies
Blood centers have the donors, resources and community footprint drug sponsors need to solve supply chain issues around cell and gene therapies.
September 15, 2026
·
6 min read
·
Becky Cap
Funding
Encoded raises $275M series F for Dravet syndrome gene therapy
Encoded Therapeutics’ lead asset ETX101 is a gene therapy being tested for Dravet syndrome. Phase 1/2 data showed substantial reductions in seizures.
September 10, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
October 2, 2026
·
4 min read
Press Releases
Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
September 21, 2026
·
9 min read
Gene editing
Reusing data could cut R&D costs and greatly increase gene editing’s reach: ARM
Leveraging recently proposed regulatory flexibilities, the gene-editing sector is working to cut R&D costs and unlock indications that were previously economically unviable, according to a new playbook published by the Alliance for Regenerative Medicine.
October 8, 2026
·
4 min read
·
Nick Paul Taylor
1 of 53,958
Next
